BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30401977)

  • 1. Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment.
    Madssen TS; Thune I; Flote VG; Lundgren S; Bertheussen GF; Frydenberg H; Wist E; Schlichting E; Schäfer H; Fjøsne HE; Vettukattil R; Lømo J; Bathen TF; Giskeødegård GF
    Br J Cancer; 2018 Oct; 119(9):1144-1154. PubMed ID: 30401977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated Administration of D-Amphetamine Induces Distinct Alterations in Behavior and Metabolite Levels in 129Sv and Bl6 Mouse Strains.
    Vanaveski T; Narvik J; Innos J; Philips MA; Ottas A; Plaas M; Haring L; Zilmer M; Vasar E
    Front Neurosci; 2018; 12():399. PubMed ID: 29946233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.
    Flote VG; Vettukattil R; Bathen TF; Egeland T; McTiernan A; Frydenberg H; Husøy A; Finstad SE; Lømo J; Garred Ø; Schlichting E; Wist EA; Thune I
    Lipids Health Dis; 2016 Mar; 15():56. PubMed ID: 26970778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein and metabolite associations to breast cancer risk in the HUNT2 study.
    Debik J; Schäfer H; Andreassen T; Wang F; Fang F; Cannet C; Spraul M; Bathen TF; Giskeødegård GF
    Br J Cancer; 2022 Nov; 127(8):1515-1524. PubMed ID: 35927310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orange juice affects acylcarnitine metabolism in healthy volunteers as revealed by a mass-spectrometry based metabolomics approach.
    Moreira V; Brasili E; Fiamoncini J; Marini F; Miccheli A; Daniel H; Lee JJH; Hassimotto NMA; Lajolo FM
    Food Res Int; 2018 May; 107():346-352. PubMed ID: 29580494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot Study of Metabolomics and Psychoneurological Symptoms in Women With Early Stage Breast Cancer.
    Lyon DE; Starkweather A; Yao Y; Garrett T; Kelly DL; Menzies V; Dereziński P; Datta S; Kumar S; Jackson-Cook C
    Biol Res Nurs; 2018 Mar; 20(2):227-236. PubMed ID: 29258398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipids in lipoproteins: compositional differences across VLDL, LDL, and HDL in pregnant women.
    Rauschert S; Gázquez A; Uhl O; Kirchberg FF; Demmelmair H; Ruíz-Palacios M; Prieto-Sánchez MT; Blanco-Carnero JE; Nieto A; Larqué E; Koletzko B
    Lipids Health Dis; 2019 Jan; 18(1):20. PubMed ID: 30670033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.
    Chhatrala R; Siddiqui MB; Stravitz RT; Driscoll C; Sanyal A; Sargeant C; Luketic V; Sharma A; Sterling R; Matherly S; Puri P; Siddiqui MS
    Liver Transpl; 2015 May; 21(5):623-30. PubMed ID: 25762084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.
    Bays H; Giezek H; McKenney JM; O'Neill EA; Tershakovec AM
    Metab Syndr Relat Disord; 2012 Aug; 10(4):260-6. PubMed ID: 22400810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
    Cao MD; Sitter B; Bathen TF; Bofin A; Lønning PE; Lundgren S; Gribbestad IS
    NMR Biomed; 2012 Feb; 25(2):369-78. PubMed ID: 21823183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic alteration induced by psychotropic drugs: Short-term metabolite profile as a predictor of weight gain evolution.
    Lenski M; Sidibé J; Gholam M; Hennart B; Dubath C; Augsburger M; von Gunten A; Conus P; Allorge D; Thomas A; Eap CB
    Clin Transl Sci; 2021 Nov; 14(6):2544-2555. PubMed ID: 34387942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic analysis of polar metabolites in lipoprotein fractions identifies lipoprotein-specific metabolic profiles and their association with insulin resistance.
    Hyötyläinen T; Mattila I; Wiedmer SK; Koivuniemi A; Taskinen MR; Yki-Järvinen H; Orešič M
    Mol Biosyst; 2012 Oct; 8(10):2559-65. PubMed ID: 22722885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samples.
    Mastrokolias A; Pool R; Mina E; Hettne KM; van Duijn E; van der Mast RC; van Ommen G; 't Hoen PA; Prehn C; Adamski J; van Roon-Mom W
    Metabolomics; 2016; 12():137. PubMed ID: 27524956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients.
    Vouk K; Ribič-Pucelj M; Adamski J; Rižner TL
    J Steroid Biochem Mol Biol; 2016 May; 159():60-9. PubMed ID: 26921767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
    Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES
    Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.